Prelude Capital Management, LLC Acrivon Therapeutics, Inc. Transaction History
Prelude Capital Management, LLC
- $1.23 Billion
- Q1 2025
A detailed history of Prelude Capital Management, LLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 13,067 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,067Holding current value
$0% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ACRV
# of Institutions
55Shares Held
22.4MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Perceptive Advisors LLC New York, NY5.36MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio